
ACB · NASDAQ
Aurora Cannabis Inc.
$5.17 -0.06 (-1.15%)
Company overview
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers, consumable vaporizer accessories, and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products, and the operation of CanvasRX, a network of cannabis counseling and outreach centers.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NASDAQ
- Market cap
- $327M
- Employees
- 1,073
- Headquarters
- Edmonton, AB
- Website
- auroramj.com
- CEO
- Miguel Martin
- Listed
- July 15, 2014
- P/E
- -3.06
- Dividend yield
- 0.00%
Company financials
- Revenue
- $363M
- Gross profit
- $180M
- Operating income
- -$4.4M
- EBITDA
- $24.2M
- Net income
- -$42.5M
- EPS
- -$1.69
- Total assets
- $775M
- Total debt
- $101M
- Gross margin
- 49.49%
- Net margin
- -11.71%
- Earnings yield
- -32.65%
No product segmentation.
Showing FY 2026
News